NYSE:JHX 7 October 2025 - 20 May 2026

James Hardie’s stock surged in early October on the Q2 news, climbing to roughly $22–$23 per share in U.S. trading. In Sydney, the stock similarly rebounded – though as of Oct 7 it traded around A$30. At ~$22 USD, the company’s market capitalization is on the order of $10–$11 billion. Even after this rally, JHX remains well below its past year’s peak: the 52-week high was about $37–$38 USD, versus a 52-week low around $18. In other words, the stock is still down ~40% from its highs, but up roughly 20–25% from its late-summer lows. In terms of fundamentals, valuation multiples reflect the company’s growth profile. JHX trades at about 23–25× forward earnings, and around 3× sales. Despite its growth investments, profitability remains strong – for instance, Jefferies noted James Hardie’s healthy gross margin of ~39% and solid liquidity. No dividend is currently paid, as the company has suspended payouts to conserve cash for expansion. The average analyst price target of ~$27 implies a forward P/E in the high teens, suggesting the market expects earnings to increase as housing conditions improve. Overall, the stock’s beta is moderate, indicating it’s less volatile than the broader market – though clearly sector-specific news